Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Item TypeItem Type
-
SubjectSubject
-
YearFrom:-To:
-
More FiltersMore FiltersSourceLanguage
Done
Filters
Reset
3
result(s) for
"Crompton, Jeff W."
Sort by:
Characterization of glacial silt and clay using automated mineralogy
2019
Glacial erosion produces vast quantities of fine-grained sediment that has a far-reaching impact on Earth surface processes. To gain a better understanding of the production of glacial silt and clay, we use automated mineralogy to quantify the microstructure and mineralogy of rock and sediment samples from 20 basins in the St. Elias Mountains, Yukon, Canada. Sediments were collected from proglacial streams, while rock samples were collected from ice marginal outcrops and fragmented using electrical pulse disaggregation. For both rock fragments and sediments, we observe a log-normal distribution of grain sizes and a sub-micrometer terminal grain size. We find that the abrasion of silt and clay results in both rounding and the exploitation of through-going fractures. The abundance of inter- versus intragranular fractures depends on mineralogy and size. Unlike the relatively larger grains, where crushing and abrasion are thought to exploit and produce discrete populations of grain sizes, the comminution of fines leads to a grain size, composition and rounding that is continuously distributed across size, and highly dependent on source-rock properties.
Journal Article
Transcriptomic evidence for modulation of host inflammatory responses during febrile Plasmodium falciparum malaria
by
Tran, Tuan M.
,
Whalen, Elizabeth
,
Bijker, Else M.
in
631/250/255/1715
,
692/699/255/1629
,
Blood
2016
Identifying molecular predictors and mechanisms of malaria disease is important for understanding how
Plasmodium falciparum
malaria is controlled. Transcriptomic studies in humans have so far been limited to retrospective analysis of blood samples from clinical cases. In this prospective, proof-of-principle study, we compared whole-blood RNA-seq profiles at pre-and post-infection time points from Malian adults who were either asymptomatic (n = 5) or febrile (n = 3) during their first seasonal PCR-positive
P. falciparum
infection with those from malaria-naïve Dutch adults after a single controlled human malaria infection (n = 5). Our data show a graded activation of pathways downstream of pro-inflammatory cytokines, with the highest activation in malaria-naïve Dutch individuals and significantly reduced activation in malaria-experienced Malians. Newly febrile and asymptomatic infections in Malians were statistically indistinguishable except for genes activated by pro-inflammatory cytokines. The combined data provide a molecular basis for the development of a pyrogenic threshold as individuals acquire immunity to clinical malaria.
Journal Article
Broadly neutralizing antibodies target the coronavirus fusion peptide
2022
The potential for future coronavirus outbreaks highlights the need to develop strategies and tools to broadly target this group of pathogens. Here, using an epitope-agnostic approach, we identified six monoclonal antibodies that bound to spike proteins from all seven human-infecting coronaviruses. Epitope mapping revealed that all six antibodies target the conserved fusion peptide region adjacent to the S2' cleavage site. Two antibodies, COV44-62 and COV44-79, broadly neutralize a range of alpha and beta coronaviruses, including SARS-CoV-2 Omicron subvariants BA.1 and BA.2, albeit with lower potency than RBD-specific antibodies. In crystal structures of Fabs COV44-62 and COV44-79 with the SARS-CoV-2 fusion peptide, the fusion peptide epitope adopts a helical structure and includes the arginine at the S2' cleavage site. Importantly, COV44-79 limited disease caused by SARS-CoV-2 in a Syrian hamster model. These findings identify the fusion peptide as the target of the broadest neutralizing antibodies in an epitope-agnostic screen, highlighting this site as a candidate for next-generation coronavirus vaccine development.
Rare monoclonal antibodies from COVID-19 convalescent individuals broadly neutralize coronaviruses by targeting the fusion peptide.
Journal Article